Papers - TERAKURA Seitaro
-
Short-term methotrexate could reduce early immune reactions and improve outcomes in umbilical cord blood transplantation for adults. Reviewed
Narimatsu H, Terakura S, Matsuo K, Oba T, Uchida T, Iida H, Hamaguchi M, Watanabe M, Kohno A, Murata M, Sawa M, Miyamura K, Morishita Y.
Bone Marrow Transplant. Vol. 39 ( 1 ) page： 31-39 2006.11
-
Increased risk for treatment-related mortality after bone marrow transplantation in GSTM1-positive recipients. Reviewed
Terakura S, Murata M, Nishida T, Emi N, Akatsuka Y, Morishima Y, Kodera Y, Naoe T.
Bone Marrow Transplant. Vol. 37 ( 4 ) page： 381-386 2006.1
-
A UGT2B17-positive donor is a risk factor for higher transplant-related mortality and lower survival after bone marrow transplantation. Reviewed
Terakura S, Murata M, Nishida T, Emi N, Akatsuka Y, Riddell SR, Morishima Y, Kodera Y, Naoe T.
Br J Haematol Vol. 129 ( 2 ) page： 221-228 2005.4
-
Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease. Reviewed
Nishida T, Hamaguchi M, Hirabayashi N, Haneda M, Terakura S, Atsuta Y, Imagama S, Kanie T, Murata M, Taji H, Suzuki R, Morishita Y, Kodera Y.
Bone Marrow Transplant. Vol. 33 ( 11 ) page： 1143-1150 2004.4